A phase III study evaluating the efficacy and safety of MBP8298 in secondary progressive MS.
Freedman MS, Bar-Or A, Oger J, Traboulsee A, Patry D, Young C, Olsson T, Li D, Hartung HP, Krantz M, Ferenczi L, Verco T; MAESTRO-01 Investigators.
Freedman MS, et al.
Neurology. 2011 Oct 18;77(16):1551-60. doi: 10.1212/WNL.0b013e318233b240. Epub 2011 Oct 5.
Neurology. 2011.
PMID: 21975206
Clinical Trial.